Published in Int J Mol Sci on January 11, 2016
Surgery increases cell death and induces changes in gene expression compared with anesthesia alone in the developing piglet brain. PLoS One (2017) 0.75
Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury. PLoS One (2017) 0.75
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 21.15
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell (1991) 11.51
Thrombin signalling and protease-activated receptors. Nature (2000) 9.27
The coagulation cascade: initiation, maintenance, and regulation. Biochemistry (1991) 6.29
Oxidative stress in Parkinson's disease. Ann Neurol (2003) 5.93
Intracerebral haemorrhage. Lancet (2009) 5.15
Proteinase-activated receptors. Pharmacol Rev (2001) 5.02
Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A (1994) 4.56
Protease-activated receptors: contribution to physiology and disease. Physiol Rev (2004) 4.49
Protease-activated receptor 3 is a second thrombin receptor in humans. Nature (1997) 3.70
Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol (1994) 3.65
Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci (1999) 3.57
Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci (2007) 3.55
Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron (2001) 3.07
Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med (1990) 2.82
Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev (2005) 2.42
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun (2012) 1.82
Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol (2013) 1.77
Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J Cell Biol (1992) 1.76
Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci (2007) 1.76
Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol (2006) 1.72
PARticipation in inflammation. J Clin Invest (2003) 1.70
The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem (2003) 1.69
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke (2012) 1.68
Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke (2007) 1.68
Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke (1999) 1.49
Serine proteases and brain damage - is there a link? Trends Neurosci (2000) 1.49
Cellular consequences of thrombin-receptor activation. Biochem J (1996) 1.45
Thrombin. Ann N Y Acad Sci (1986) 1.44
Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg (1997) 1.42
Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia (2005) 1.40
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci U S A (2003) 1.40
Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40
Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci (2000) 1.38
Prothrombin mRNA is expressed by cells of the nervous system. Neuron (1991) 1.38
Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci (2001) 1.37
Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci (1995) 1.37
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci U S A (2000) 1.34
Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol (2006) 1.33
Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin. Arterioscler Thromb Vasc Biol (2010) 1.31
Protease-activated receptors start a family. Proc Natl Acad Sci U S A (1994) 1.30
The clot thickens: clues provided by thrombin structure. Trends Biochem Sci (1995) 1.30
Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci (2005) 1.28
Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci U S A (2005) 1.26
Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J Neurosci (2006) 1.25
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med (2006) 1.25
Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. J Alzheimers Dis (2006) 1.24
Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci (1995) 1.22
Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J Neurosci (2005) 1.21
Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I. J Biol Chem (1997) 1.20
Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol (2002) 1.18
Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia (2002) 1.14
Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol (1994) 1.13
Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem (2002) 1.12
Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J Neuropathol Exp Neurol (2006) 1.12
Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg (1996) 1.12
Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem (2005) 1.11
Thrombin signaling in the brain: the role of protease-activated receptors. Biol Chem (2003) 1.10
Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development. Development (1993) 1.10
Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J Cereb Blood Flow Metab (2004) 1.10
Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience (1998) 1.10
Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol (2006) 1.09
Thrombin-induced activation of cultured rodent microglia. J Neurochem (2000) 1.09
Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci (2003) 1.08
Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab (2002) 1.06
Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol (2003) 1.05
Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost (2008) 1.05
HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc (2013) 1.04
Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci (1998) 1.04
Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol (2005) 1.04
PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia. J Cereb Blood Flow Metab (2004) 1.02
Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J Neurochem (2006) 1.01
Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats. Stroke (2009) 1.01
Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem (2000) 1.00
Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2002) 1.00
Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis (2006) 1.00
Acquired immunodeficiency syndrome and the blood-brain barrier. J Neurovirol (2009) 1.00
Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp Neurol (2007) 1.00
Holo-transferrin and thrombin can interact to cause brain damage. Stroke (2005) 0.99
Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem (2003) 0.98
Hirudin as alternative anticoagulant--a historical review. Semin Thromb Hemost (2002) 0.98
Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett (1992) 0.98
Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci Lett (2002) 0.97
Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures. Neurobiol Dis (2005) 0.97
Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem (2007) 0.94
Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. J Neurosci Res (2004) 0.94
Thrombin potently enhances swelling-sensitive glutamate efflux from cultured astrocytes. Glia (2007) 0.94
Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J Biol Chem (2003) 0.92
Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol (1990) 0.91
Coagulation factor Xa activates thrombin in ischemic neural tissue. J Neurochem (2009) 0.91
Role of the clotting system in the pathogenesis of neuroimmunologic disease. Fed Proc (1987) 0.90
Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease. Brain Res (2006) 0.90
Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family. Eur J Neurosci (2007) 0.90
Molecular mechanisms of thrombin signaling. Semin Hematol (1994) 0.89
Thrombin exacerbates brain edema in focal cerebral ischemia. Acta Neurochir Suppl (2003) 0.88
Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by beta-amyloid in vitro. J Neurochem (1996) 0.88
Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention? CNS Drugs (2002) 0.88
Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins. Neurobiol Dis (2003) 0.88